New Oriental Kicks Off FY2027 With Q1 Results; Focus Turns to Deferred Revenue and Domestic Prep

What happened

New Oriental announced first-quarter fiscal 2027 results on October 28, 2026, marking the first update after a robust FY2026 close. The prior fiscal year delivered 15.5% revenue growth to $5.66 billion and operating margin expansion to 11.4%, with deferred revenue up 14.8% to $2.24 billion. Management guided FY2027 revenue growth of 14-18%, and the market will focus on whether deferred revenue growth remains within that range. The master report's key concern is the narrow growth mix, as overseas test-prep grew only 3.6% in Q4 FY2026 while domestic adult/university prep surged 29.1%. Today's release will test whether that domestic engine can continue to offset overseas weakness and support the current 18.5x P/E multiple.

Implication

Investors should hold current positions and monitor the next few quarters. If Q1 FY2027 shows deferred revenue growth above 14% and domestic adult/university test-prep growth above 20%, the case for a higher valuation strengthens, potentially moving the rating toward a buy. However, if deferred revenue growth drops below 10% or overseas test-prep remains stalled, the stock could drift toward the $49 support level. The strong balance sheet and buyback program provide downside protection, but upside above $64 requires consistent mid-teens growth and margin improvement.

Thesis delta

No immediate thesis shift. The Q1 FY2027 results are the first direct test of the durability narrative; confirmation of strong deferred revenue and domestic growth would support maintaining or improving the WAIT rating, while weaker numbers would increase the bear case odds. The core debate remains whether one strong domestic engine can support the current valuation.